I believe the Australian share market is home to a good number of small-cap shares with significant growth potential.
Below you will find three shares which I think deserve to be added to your watchlist today. They are as follows:
Cynata Therapeutics Ltd (ASX: CYP)
Cynata’s impressive Cymerus technology is able to produce an unlimited number of high quality and consistent stem cells at a low cost which can then be used to treat a number of diseases. One such disease that Cynata is targeting is Graft versus Host Disease (GvHD). Japanese-giant FUJIFILM has a global license to market and sell its therapeutic MSC product CYP-001 for the treatment of GvHD and estimates the market to be worth up to US$300 million a year. The double-digit royalties from these sales will ultimately fall straight to Cynata’s bottom line.
Fastbrick Robotics Ltd (ASX: FBR)
I think this robotics company’s Hadrian X bricklaying robot could be on the verge of disrupting the homebuilding industry. The robot can lay 1,000 standard brick equivalents per hour, compared to the 400 bricks that a typical bricklayer lays per day. The company has US-giant Caterpillar as a strategic partner and recently announced a major memorandum of understanding to build 50,000 new homes in Saudi Arabia. By my calculations, this deal could be worth upwards of $200 million to Fastbrick Robotics.
LiveHire Ltd (ASX: LVH)
This fast-growing talent technology company provides its users with a platform which creates a pool of pre-qualified job candidates to access when they need to recruit. By doing things in this way, it saves recruiters both time and money. I’ve been very impressed at the number of big name companies that have signed up to use its service. These include companies such as Roy Hill, Randstad (Singapore), Bupa, Queensland Health, and Wesfarmers Ltd (ASX: WES).
Finally, just like Fastbrick Robotics, I think this quality tech share could potentially benefit from Saudi Arabia's construction boom.
On 9 March, the visionary Tesla co-founder and CEO made a bold $63,000,000 to save a large swath of Australia. But in the process, he accidentally revealed the small Melbourne-based company that allows him to consistently make the impossible possible. At one point, this little understood company was actually the single most heavily shorted share in all of the ASX. Yet oddly enough, nine out of 10 analysts call it a screaming BUY! And that includes Motley Fool Australia.
We just isolated this company as Elon Musk’s “secret weapon”, and think it’s dynamic run (up more than double after initially floating shares just two and a half years ago!) is only getting started. For the full story on this company, as well as how to get invested alongside us today, simply click here!
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.